Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 13 | 2021 | 108 | 2.030 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2021 | 39 | 1.120 |
Why?
|
| Critical Illness | 2 | 2022 | 135 | 0.870 |
Why?
|
| Consciousness Disorders | 1 | 2022 | 7 | 0.820 |
Why?
|
| Brain Diseases | 1 | 2021 | 67 | 0.710 |
Why?
|
| Hospital Mortality | 8 | 2022 | 147 | 0.670 |
Why?
|
| Fever | 1 | 2017 | 36 | 0.540 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2021 | 96 | 0.400 |
Why?
|
| Time Factors | 11 | 2020 | 1501 | 0.370 |
Why?
|
| Humans | 33 | 2022 | 28560 | 0.350 |
Why?
|
| Drainage | 3 | 2021 | 49 | 0.340 |
Why?
|
| Brain Ischemia | 2 | 2021 | 63 | 0.340 |
Why?
|
| Stroke | 4 | 2017 | 275 | 0.330 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 114 | 0.330 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 990 | 0.320 |
Why?
|
| Female | 23 | 2021 | 15818 | 0.320 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 121 | 0.290 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 150 | 0.290 |
Why?
|
| Brain Edema | 2 | 2020 | 18 | 0.280 |
Why?
|
| Encephalocele | 2 | 2020 | 24 | 0.280 |
Why?
|
| Middle Aged | 18 | 2021 | 9316 | 0.280 |
Why?
|
| Male | 23 | 2021 | 15400 | 0.280 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 29 | 0.270 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2019 | 9 | 0.270 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3612 | 0.270 |
Why?
|
| Risk Factors | 8 | 2021 | 2412 | 0.260 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 59 | 0.250 |
Why?
|
| Cerebral Ventricles | 2 | 2017 | 19 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2021 | 1807 | 0.250 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 42 | 0.240 |
Why?
|
| Hydrocephalus | 2 | 2021 | 19 | 0.230 |
Why?
|
| Critical Care | 3 | 2020 | 199 | 0.220 |
Why?
|
| Intracranial Thrombosis | 2 | 2020 | 6 | 0.210 |
Why?
|
| Consciousness | 1 | 2022 | 4 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2021 | 677 | 0.200 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.200 |
Why?
|
| Length of Stay | 3 | 2021 | 328 | 0.200 |
Why?
|
| Aged | 15 | 2021 | 9334 | 0.190 |
Why?
|
| Hospitals | 1 | 2022 | 156 | 0.190 |
Why?
|
| Pandemics | 2 | 2020 | 260 | 0.190 |
Why?
|
| Leukocytosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 322 | 0.180 |
Why?
|
| Cerebrum | 1 | 2021 | 11 | 0.180 |
Why?
|
| Brain Death | 1 | 2020 | 9 | 0.180 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 8 | 0.180 |
Why?
|
| Neurologists | 1 | 2020 | 4 | 0.180 |
Why?
|
| Occupational Health | 1 | 2020 | 22 | 0.180 |
Why?
|
| Apnea | 1 | 2020 | 15 | 0.180 |
Why?
|
| Health Care Rationing | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 32 | 0.180 |
Why?
|
| Cerebral Angiography | 3 | 2021 | 35 | 0.170 |
Why?
|
| Logistic Models | 3 | 2017 | 396 | 0.170 |
Why?
|
| Rivaroxaban | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 7 | 0.170 |
Why?
|
| Hemostasis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Pyridones | 1 | 2020 | 11 | 0.170 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hemostatics | 1 | 2020 | 13 | 0.170 |
Why?
|
| Prognosis | 3 | 2020 | 826 | 0.170 |
Why?
|
| Pregnancy | 1 | 2021 | 341 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2020 | 80 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 108 | 0.170 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 19 | 0.170 |
Why?
|
| Seizures | 1 | 2020 | 65 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 10 | 0.170 |
Why?
|
| Endocarditis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Neurology | 1 | 2020 | 58 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2019 | 36 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2020 | 58 | 0.160 |
Why?
|
| Delirium | 1 | 2018 | 14 | 0.160 |
Why?
|
| Disease Management | 1 | 2019 | 114 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 196 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 90 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 331 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 94 | 0.150 |
Why?
|
| Adult | 10 | 2021 | 8168 | 0.140 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2017 | 1 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.140 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 56 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 146 | 0.130 |
Why?
|
| Sodium Chloride | 1 | 2017 | 36 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 268 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 231 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 939 | 0.120 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 50 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2021 | 3620 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 4894 | 0.110 |
Why?
|
| Troponin I | 1 | 2013 | 12 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 15 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2012 | 13 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 2102 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 26 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 496 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 90 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 4 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 772 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1194 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 6 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 13 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 17 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 35 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 259 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2021 | 66 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 75 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 162 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 298 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 788 | 0.070 |
Why?
|
| Intensive Care Units | 2 | 2020 | 299 | 0.070 |
Why?
|
| Incidence | 2 | 2019 | 774 | 0.060 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2017 | 9 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2020 | 300 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 601 | 0.060 |
Why?
|
| United States | 2 | 2020 | 2197 | 0.050 |
Why?
|
| Hypertension | 2 | 2018 | 245 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 6 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 6 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1695 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 31 | 0.050 |
Why?
|
| Patient Admission | 1 | 2021 | 26 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2020 | 57 | 0.040 |
Why?
|
| Registries | 2 | 2012 | 188 | 0.040 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 11 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2020 | 23 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 22 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 19 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 21 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 43 | 0.040 |
Why?
|
| Physician Assistants | 1 | 2020 | 16 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 44 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 7 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 114 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 16 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 28 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 82 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 137 | 0.040 |
Why?
|
| Nurses | 1 | 2020 | 56 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 62 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 77 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 153 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 291 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 519 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 66 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 322 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 109 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 501 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 214 | 0.040 |
Why?
|
| Physicians | 1 | 2020 | 123 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 358 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 476 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 249 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2017 | 20 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 38 | 0.040 |
Why?
|
| Glucose | 1 | 2017 | 56 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 735 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1395 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 352 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 7 | 0.030 |
Why?
|
| Plasma | 1 | 2012 | 19 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 18 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2013 | 433 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 176 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 7 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 8 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 467 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2319 | 0.020 |
Why?
|